C

China Dasheng Biotechnology Co
OTC:CDBT

Watchlist Manager
China Dasheng Biotechnology Co
OTC:CDBT
Watchlist
Price: 0.0424 USD 37.22% Market Closed
Market Cap: $1.7m

China Dasheng Biotechnology Co
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

China Dasheng Biotechnology Co
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
C
China Dasheng Biotechnology Co
OTC:CDBT
Inventory
$562k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sherwin-Williams Co
NYSE:SHW
Inventory
$2.3B
CAGR 3-Years
-4%
CAGR 5-Years
5%
CAGR 10-Years
9%
International Flavors & Fragrances Inc
NYSE:IFF
Inventory
$2.4B
CAGR 3-Years
-9%
CAGR 5-Years
16%
CAGR 10-Years
15%
Ecolab Inc
NYSE:ECL
Inventory
$1.5B
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
1%
PPG Industries Inc
NYSE:PPG
Inventory
$2B
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
2%
Albemarle Corp
NYSE:ALB
Inventory
$1.2B
CAGR 3-Years
-17%
CAGR 5-Years
9%
CAGR 10-Years
10%
No Stocks Found

China Dasheng Biotechnology Co
Glance View

Market Cap
1.7m USD
Industry
Chemicals

China Dasheng Biotechnology Co. engages in the development, manufacture and sale of bacteria based products, which are used as additives for livestock feed and crop cultivation. The company is headquartered in Scottsdale, Arizona and currently employs 689 full-time employees. The company went IPO on 2008-02-13. The firm is not engaged in any business and has not generated any revenue.

CDBT Intrinsic Value
Not Available
C

See Also

What is China Dasheng Biotechnology Co's Inventory?
Inventory
562k USD

Based on the financial report for Jun 30, 2008, China Dasheng Biotechnology Co's Inventory amounts to 562k USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett